122 related articles for article (PubMed ID: 9753066)
1. Coexpression of erythroid and megakaryocytic genes in acute erythroblastic (FAB M6) and megakaryoblastic (FAB M7) leukaemias.
Linari S; Vannucchi AM; Ciolli S; Leoni F; Caporale R; Grossi A; Pagliai G; Santini V; Paoletti F; Ferrini PR
Br J Haematol; 1998 Sep; 102(5):1335-7. PubMed ID: 9753066
[TBL] [Abstract][Full Text] [Related]
2. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
[TBL] [Abstract][Full Text] [Related]
3. Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells.
Drexler HG; Quentmeier H
Leukemia; 1996 Sep; 10(9):1405-21. PubMed ID: 8751457
[TBL] [Abstract][Full Text] [Related]
4. Coexpression of thrombopoietin and c-mpl genes in human acute myeloblastic leukemia cells.
Matsumura I; Kanakura Y; Ikeda H; Ishikawa J; Yoshida H; Horikawa Y; Nishiura T; Tahara T; Kato T; Miyazaki H; Matsuzawa Y
Leukemia; 1996 Jan; 10(1):91-4. PubMed ID: 8558944
[TBL] [Abstract][Full Text] [Related]
5. Expression of erythroid-specific genes in megakaryoblastic disorders.
Ito E; Kasai M; Toki T; Arai K; Yokoyama M
Leuk Lymphoma; 1996 Nov; 23(5-6):545-50. PubMed ID: 9031085
[TBL] [Abstract][Full Text] [Related]
6. Expression of erythroid-specific genes in acute megakaryoblastic leukaemia and transient myeloproliferative disorder in Down's syndrome.
Ito E; Kasai M; Hayashi Y; Toki T; Arai K; Yokoyama S; Kato K; Tachibana N; Yamamoto M; Yokoyama M
Br J Haematol; 1995 Jul; 90(3):607-14. PubMed ID: 7647001
[TBL] [Abstract][Full Text] [Related]
7. Growth stimulatory effect of thrombopoietin on the blast cells of acute myelogenous leukaemia.
Motoji T; Takanashi M; Motomura S; Wang WH; Shiozaki H; Aoyama M; Mizoguchi H
Br J Haematol; 1996 Sep; 94(3):513-6. PubMed ID: 8790152
[TBL] [Abstract][Full Text] [Related]
8. The effects of thrombopoietin on the growth of acute myeloblastic leukemia cells.
Matsumura I; Ikeda H; Kanakura Y
Leuk Lymphoma; 1996 Nov; 23(5-6):533-8. PubMed ID: 9031083
[TBL] [Abstract][Full Text] [Related]
9. Use of human leukemia-lymphoma cell lines in hematological research: effects of thrombopoietin on human leukemia cell lines.
Drexler HG; Quentmeier H
Hum Cell; 1996 Dec; 9(4):309-16. PubMed ID: 9183663
[TBL] [Abstract][Full Text] [Related]
10. Quantitative expression of thrombopoietin receptor on leukaemia cells from patients with acute myeloid leukaemia and acute lymphoblastic leukaemia.
Takeshita A; Shinjo K; Izumi M; Ling P; Nakamura S; Naito K; Ohnishi K; Ohno R
Br J Haematol; 1998 Feb; 100(2):283-90. PubMed ID: 9488614
[TBL] [Abstract][Full Text] [Related]
11. Growth factor-independent 1B gene (GFI1B) is overexpressed in erythropoietic and megakaryocytic malignancies and increases their proliferation rate.
Elmaagacli AH; Koldehoff M; Zakrzewski JL; Steckel NK; Ottinger H; Beelen DW
Br J Haematol; 2007 Jan; 136(2):212-9. PubMed ID: 17156408
[TBL] [Abstract][Full Text] [Related]
12. Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: report from the Children's Oncology Group.
Barnard DR; Alonzo TA; Gerbing RB; Lange B; Woods WG;
Pediatr Blood Cancer; 2007 Jul; 49(1):17-22. PubMed ID: 16856158
[TBL] [Abstract][Full Text] [Related]
13. An erythroid and megakaryocytic common precursor cell line (B1647) expressing both c-mpl and erythropoietin receptor (Epo-R) proliferates and modifies globin chain synthesis in response to megakaryocyte growth and development factor (MGDF) but not to erythropoietin (Epo).
Bonsi L; Grossi A; Strippoli P; Tumietto F; Tonelli R; Vannucchi AM; Ronchi A; Ottolenghi S; Visconti G; Avanzi GC; Pegoraro L; Bagnara GP
Br J Haematol; 1997 Sep; 98(3):549-59. PubMed ID: 9332307
[TBL] [Abstract][Full Text] [Related]
14. [Study of thrombopoietin and its receptor C-mpl in acute leukemia].
Guo Y; Bian S; Luo M
Zhonghua Xue Ye Xue Za Zhi; 1999 Mar; 20(3):120-3. PubMed ID: 11601235
[TBL] [Abstract][Full Text] [Related]
15. Effect of thrombopoietin on proliferation of blasts from CD7-positive acute myelogenous leukaemia.
Tokunaga Y; Miyamoto T; Okamura T; Eto T; Gondo H; Kamimura T; Okamura S; Niho Y
Br J Haematol; 1998 Sep; 102(5):1232-40. PubMed ID: 9753051
[TBL] [Abstract][Full Text] [Related]
16. Effect of thrombopoietin on acute myelogenous leukemia blasts.
Tokunaga Y; Miyamoto T; Gondo H; Okamura T; Niho Y
Leuk Lymphoma; 2000 Mar; 37(1-2):27-37. PubMed ID: 10721767
[TBL] [Abstract][Full Text] [Related]
17. Quantitative expression of erythropoietin receptor (EPO-R) on acute leukaemia cells: relationships between the amount of EPO-R and CD phenotypes, in vitro proliferative response, the amount of other cytokine receptors and clinical prognosis. Japan Adult Leukaemia Study Group.
Takeshita A; Shinjo K; Higuchi M; Miyawaki S; Takemoto Y; Kishimoto Y; Saito K; Takuchi H; Kuriyama K; Kimura Y; Asou N; Takahashi M; Hotta T; Kanamaru A; Ueda R; Ohno R
Br J Haematol; 2000 Jan; 108(1):55-63. PubMed ID: 10651724
[TBL] [Abstract][Full Text] [Related]
18. GATA-1 is expressed in acute erythroblastic leukaemia.
Ekert H; Sievers EL; Tan A; Martin DI; Smith FO; Barnard D; Bernstein ID
Br J Haematol; 1994 Feb; 86(2):410-2. PubMed ID: 8199039
[TBL] [Abstract][Full Text] [Related]
19. Thrombopoietin induces histidine decarboxylase gene expression in c-mpl transfected UT7 cells.
Pacilio M; Debili N; Arnould A; Machavoine F; Rolli-Derkinderen M; Bodger M; Arock M; Duménil D; Dy M; Schneider E
Biochem Biophys Res Commun; 2001 Aug; 285(5):1095-101. PubMed ID: 11478766
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis of erythroid precursors under stimulation with thrombopoietin: contribution to megakaryocytic lineage choice.
Sawai N; Koike K; Ito S; Kurokawa Y; Mwamtemi HH; Kinoshita T; Sakashita K; Higuchi T; Takeuchi K; Shiohara M; Ogami K; Komiyama A
Stem Cells; 1999; 17(1):45-53. PubMed ID: 10215401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
